<!DOCTYPE html>
<html lang="en">
<head>
  <!-- Google tag (gtag.js) -->
  <script async src="https://www.googletagmanager.com/gtag/js?id=G-LSRR4KW715"></script>
  <script>
    window.dataLayer = window.dataLayer || [];
    function gtag(){dataLayer.push(arguments);
    }
    gtag('js', new Date());

    gtag('config', 'G-LSRR4KW715');
  </script>


  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>Case 24.7 - Pre-Menstrual Syndrome & Dysphoric Disorder</title>

  <!-- Favicon -->
  <link rel="icon" type="image/png" href="../assets/ShepTech logo.png">
  <link rel="apple-touch-icon" href="../assets/ShepTech logo.png">

  <!-- Primary Meta Tags -->
  <meta name="title" content="Case 24.7 - Pre-Menstrual Syndrome & Dysphoric Disorder | MD3 SCP Cases">
  <meta name="description" content="A 30-year-old with severe premenstrual mood symptoms. Learn about PMS vs PMDD diagnosis, symptom diaries, and management with lifestyle, COCP, SSRIs, and GnRH analogues.">

  <!-- Open Graph / Facebook -->
  <meta property="fb:app_id" content="your_facebook_app_id">
  <meta property="og:type" content="article">
  <meta property="og:url" content="https://md3-scp.netlify.app/cases/case24_7.html">
  <meta property="og:title" content="Case 24.7 - Pre-Menstrual Syndrome & Dysphoric Disorder">
  <meta property="og:site_name" content="MD3 SCP Cases">
  <meta property="og:description" content="A 30-year-old with severe premenstrual mood symptoms. Learn about PMS vs PMDD diagnosis, symptom diaries, and management with lifestyle, COCP, SSRIs, and GnRH analogues.">
  <meta property="og:image" content="https://md3-scp.netlify.app/assets/ShepTech%20logo.png">
  <!-- Twitter -->
  <meta property="twitter:card" content="summary">
  <meta property="twitter:title" content="Case 24.7 - Pre-Menstrual Syndrome & Dysphoric Disorder">
  <meta property="twitter:description" content="A 30-year-old with severe premenstrual mood symptoms. Learn about PMS vs PMDD diagnosis, symptom diaries, and management with lifestyle, COCP, SSRIs, and GnRH analogues.">
  <meta property="twitter:image" content="https://md3-scp.netlify.app/assets/ShepTech%20logo.png">

  <link rel="stylesheet" href="../css/case.css">

  <!-- Firebase SDK -->
  <script src="https://www.gstatic.com/firebasejs/9.22.0/firebase-app-compat.js"></script>
  <script src="https://www.gstatic.com/firebasejs/9.22.0/firebase-auth-compat.js"></script>
  <script src="https://www.gstatic.com/firebasejs/9.22.0/firebase-firestore-compat.js"></script>
</head>
<body>
  <div class="container">
    <div class="case-header">
      <a href="#" class="back-link" onclick="goBack(event)">← Back to Cases</a>
    </div>

    <h1>Case 24.7 – Pre-Menstrual Syndrome & Dysphoric Disorder</h1>
    <p class="meta"><strong>Category:</strong> Medicine | <strong>Discipline:</strong> Obstetrics & Gynaecology | <strong>Setting:</strong> GP Surgery</p>

    <h2>Case</h2>
    <p>Mrs. Hannah Roberts, a 30-year-old office manager, presents to her GP with severe premenstrual symptoms that have progressively worsened over the past 2 years. She reports that for 7-10 days before each period, she experiences intense mood swings, irritability, anxiety, and low mood. She describes feeling "out of control" and has had several arguments with her husband during this time. She also experiences breast tenderness, bloating, and food cravings (especially chocolate and carbohydrates).</p>

    <p>Her symptoms begin around day 18-21 of her cycle (luteal phase) and resolve within 1-2 days of her period starting. She feels "completely normal" for the first 2 weeks of her cycle (follicular phase). The severity of her symptoms has led to her taking sick days from work and has strained her relationship with her husband.</p>

    <p>Hannah has regular 28-day menstrual cycles with moderate flow lasting 5 days. She denies heavy bleeding, intermenstrual bleeding, or pelvic pain outside of the premenstrual phase. She has no history of depression or anxiety disorders, though she did experience mild postnatal depression after the birth of her second child 3 years ago (resolved with counselling). She is not currently using contraception as she and her husband have completed their family (2 children aged 3 and 5).</p>

    <p>Past medical history is unremarkable. She takes no regular medications. She drinks 5-10 units of alcohol per week and is a non-smoker. There is a family history of depression (mother).</p>

    <div class="vital-signs">
      <strong>On Examination:</strong>
      <ul>
        <li>General: BMI 26, appears well (seen during follicular phase - no symptoms currently)</li>
        <li>Vital signs: BP 122/78 mmHg, HR 74 bpm</li>
        <li>Abdominal examination: Soft, non-tender, no masses</li>
        <li>Mental state: Normal affect, no evidence of low mood or anxiety (follicular phase)</li>
      </ul>
    </div>

    <h2>Symptom Diary (2 Cycles)</h2>
    <div class="investigation-results">
      <p>Hannah was asked to complete a prospective symptom diary over 2 menstrual cycles, rating symptoms daily (0-3 scale: 0=none, 3=severe):</p>
      <strong>Follicular Phase (Days 1-14):</strong>
      <ul>
        <li>Mood symptoms: 0-1 (minimal)</li>
        <li>Physical symptoms: 0-1 (minimal)</li>
      </ul>
      <strong>Luteal Phase (Days 18-28):</strong>
      <ul>
        <li><strong>Mood symptoms: 2-3 (severe)</strong>
          <ul>
            <li>Irritability/anger: 3</li>
            <li>Mood swings: 3</li>
            <li>Anxiety: 2-3</li>
            <li>Low mood/crying: 2</li>
            <li>Feeling overwhelmed: 3</li>
          </ul>
        </li>
        <li><strong>Physical symptoms: 2</strong>
          <ul>
            <li>Breast tenderness: 2</li>
            <li>Bloating: 2</li>
            <li>Food cravings: 2</li>
            <li>Fatigue: 2</li>
          </ul>
        </li>
      </ul>
      <p><strong>Clear luteal phase pattern with symptom-free interval in follicular phase → Confirms cyclical premenstrual disorder</strong></p>
    </div>

    <h2>Questions</h2>

        <div class="question">
      <strong>Question 1: What is the difference between PMS and PMDD, and how are they diagnosed?</strong><br>
      <button class="toggle">Show Answer</button>
      <div class="answer">
        <p><strong>Definitions:</strong></p>

        <p><strong>Premenstrual Syndrome (PMS):</strong></p>
        <ul>
          <li>Cyclical physical, psychological, and behavioural symptoms occurring in the <strong>luteal phase</strong> (after ovulation, days 14-28) that resolve shortly after menstruation starts</li>
          <li>Affects 20-40% of menstruating women</li>
          <li>Symptoms cause mild-moderate impairment in daily functioning</li>
        </ul>

        <p><strong>Premenstrual Dysphoric Disorder (PMDD):</strong></p>
        <ul>
          <li>Severe form of PMS with predominantly <strong>mood/psychological symptoms</strong> that cause significant functional impairment</li>
          <li>Affects 3-8% of menstruating women</li>
          <li>Recognized as a psychiatric disorder in DSM-5</li>
          <li>Symptoms severely impact work, relationships, and quality of life</li>
        </ul>

        <p><strong>Common Symptoms:</strong></p>

        <p><strong>Psychological/Mood symptoms:</strong></p>
        <ul>
          <li>Mood swings, irritability, anger</li>
          <li>Depression, low mood, crying</li>
          <li>Anxiety, tension, feeling "on edge"</li>
          <li>Difficulty concentrating, confusion</li>
          <li>Feeling overwhelmed or out of control</li>
          <li>Social withdrawal, reduced interest in activities</li>
        </ul>

        <p><strong>Physical symptoms:</strong></p>
        <ul>
          <li>Breast tenderness (mastalgia)</li>
          <li>Bloating, weight gain (fluid retention)</li>
          <li>Headaches, joint/muscle pain</li>
          <li>Fatigue, lethargy</li>
          <li>Food cravings (especially sweet/salty foods)</li>
          <li>Sleep disturbance (insomnia or hypersomnia)</li>
        </ul>

        <p><strong>Diagnostic Criteria (Both PMS and PMDD):</strong></p>

        <p><strong>1. Timing - Essential Features:</strong></p>
        <ul>
          <li><strong>Symptoms occur in luteal phase</strong> (after ovulation, typically days 14-28 of cycle)</li>
          <li><strong>Resolve within days of menstruation starting</strong> (follicular phase)</li>
          <li><strong>Symptom-free interval in follicular phase</strong> (days 1-14) - this is KEY for diagnosis</li>
          <li>Pattern consistent across ≥2 consecutive menstrual cycles</li>
        </ul>

        <p><strong>2. Symptom Severity:</strong></p>
        <ul>
          <li><strong>PMS:</strong> Mild-moderate impairment in daily activities, work, relationships</li>
          <li><strong>PMDD:</strong> Severe impairment - inability to work, significant relationship strain, suicidal ideation (rare but reported)</li>
        </ul>

        <p><strong>3. Exclusion of Other Causes:</strong></p>
        <ul>
          <li>Not due to medications, substance use, or another medical condition</li>
          <li>Not an exacerbation of underlying psychiatric disorder (e.g., depression, anxiety, bipolar disorder)
            <ul>
              <li><strong>Key difference:</strong> PMS/PMDD patients have <strong>symptom-free follicular phase</strong>, while those with depression/anxiety have continuous symptoms</li>
            </ul>
          </li>
        </ul>

        <p><strong>Diagnosis - Prospective Symptom Diary (ESSENTIAL):</strong></p>
        <ul>
          <li><strong>Daily symptom diary for ≥2 consecutive menstrual cycles</strong> (mandatory for diagnosis)</li>
          <li>Rate symptoms daily (e.g., 0-3 scale: 0=none, 3=severe)</li>
          <li>Record: Mood symptoms (irritability, anxiety, low mood), physical symptoms (bloating, breast pain), menstruation dates</li>
          <li><strong>Confirms cyclical pattern:</strong> Symptoms in luteal phase, symptom-free interval in follicular phase</li>
          <li><strong>Differentiates from:</strong>
            <ul>
              <li>Depression/anxiety (symptoms present throughout cycle, no symptom-free interval)</li>
              <li>Premenstrual exacerbation of underlying disorder (symptoms worse premenstrually but still present in follicular phase)</li>
            </ul>
          </li>
        </ul>

        <p><strong>PMDD Diagnostic Criteria (DSM-5) - Requires ≥5 of the following, with ≥1 core symptom:</strong></p>

        <p><strong>Core symptoms (≥1 required):</strong></p>
        <ul>
          <li>Marked mood swings</li>
          <li>Marked irritability or anger</li>
          <li>Marked depressed mood, hopelessness</li>
          <li>Marked anxiety, tension</li>
        </ul>

        <p><strong>Additional symptoms:</strong></p>
        <ul>
          <li>Decreased interest in activities</li>
          <li>Difficulty concentrating</li>
          <li>Fatigue, low energy</li>
          <li>Change in appetite, food cravings</li>
          <li>Sleep disturbance</li>
          <li>Feeling overwhelmed or out of control</li>
          <li>Physical symptoms (breast tenderness, bloating)</li>
        </ul>

        <p><strong>This patient's diagnosis:</strong></p>
        <ul>
          <li><strong>Prospective diary confirms:</strong> Severe mood symptoms (irritability, mood swings, anxiety, low mood) in luteal phase (days 18-28), symptom-free follicular phase (days 1-14)</li>
          <li><strong>Functional impairment:</strong> Sick days from work, relationship strain</li>
          <li><strong>Meets ≥5 DSM-5 criteria</strong> including core mood symptoms</li>
          <li><strong>Diagnosis: Premenstrual Dysphoric Disorder (PMDD)</strong></li>
        </ul>
      </div>
    </div>

        <div class="question">
      <strong>Question 2: How is PMS/PMDD managed?</strong><br>
      <button class="toggle">Show Answer</button>
      <div class="answer">
        <p><strong>Management of PMS/PMDD - Stepwise Approach:</strong></p>

        <p><strong>1. Lifestyle Modifications (First-line for ALL patients):</strong></p>
        <ul>
          <li><strong>Exercise:</strong> Regular aerobic exercise (30 mins, 5x/week) - proven to reduce PMS symptoms</li>
          <li><strong>Diet:</strong>
            <ul>
              <li>Complex carbohydrates (whole grains) - stabilize blood sugar, reduce cravings</li>
              <li>Reduce caffeine, alcohol, salt, refined sugar</li>
              <li>Frequent small meals (reduce bloating)</li>
            </ul>
          </li>
          <li><strong>Sleep hygiene:</strong> Regular sleep pattern, 7-9 hours/night</li>
          <li><strong>Stress management:</strong> Cognitive behavioural therapy (CBT), relaxation techniques, mindfulness, yoga</li>
        </ul>

        <p><strong>2. Dietary Supplements (Evidence-based):</strong></p>
        <ul>
          <li><strong>Vitamin B6 (pyridoxine) 50-100mg daily:</strong> May reduce mood symptoms</li>
          <li><strong>Calcium 1000-1200mg daily:</strong> May reduce physical and mood symptoms</li>
          <li><strong>Magnesium 200-400mg daily:</strong> May reduce bloating, breast tenderness</li>
          <li><strong>Evening primrose oil:</strong> Weak evidence (not routinely recommended)</li>
        </ul>

        <p><strong>3. Pharmacological Management:</strong></p>

        <p><strong>A) For Mild-Moderate PMS:</strong></p>
        <ul>
          <li><strong>NSAIDs (mefenamic acid 500mg TDS):</strong> For physical symptoms (breast pain, headaches, dysmenorrhoea)</li>
          <li><strong>Combined Oral Contraceptive Pill (COCP):</strong>
            <ul>
              <li><strong>Continuous regimen</strong> (back-to-back, no pill-free interval) - suppresses ovulation, eliminates luteal phase</li>
              <li><strong>Yasmin (drospirenone + ethinylestradiol)</strong> - anti-mineralocorticoid progestogen, reduces bloating/fluid retention</li>
              <li><strong>Takes 3-6 months</strong> to see full benefit</li>
            </ul>
          </li>
        </ul>

        <p><strong>B) For Severe PMS / PMDD (First-line pharmacological):</strong></p>
        <ul>
          <li><strong>SSRIs (Selective Serotonin Reuptake Inhibitors) - MOST EFFECTIVE for PMDD:</strong>
            <ul>
              <li><strong>Fluoxetine 20mg, sertraline 50-150mg, citalopram 20mg, escitalopram 10-20mg</strong></li>
              <li><strong>Dosing options:</strong>
                <ul>
                  <li><strong>Continuous daily:</strong> Take every day throughout cycle</li>
                  <li><strong>Luteal phase only (days 14-28):</strong> Start after ovulation, stop when period starts (as effective as continuous, lower side effects)</li>
                </ul>
              </li>
              <li><strong>Mechanism:</strong> Low serotonin implicated in PMDD - SSRIs rapidly (within days) improve mood symptoms</li>
              <li><strong>Efficacy:</strong> 60-70% symptom improvement</li>
              <li><strong>Onset:</strong> Effect within 1-2 days (unlike depression where takes 2-4 weeks)</li>
              <li><strong>Side effects:</strong> Nausea, sexual dysfunction, insomnia (usually mild)</li>
            </ul>
          </li>
        </ul>

        <p><strong>C) For Refractory PMDD (Second-line if SSRIs + COCP fail):</strong></p>
        <ul>
          <li><strong>GnRH analogues (goserelin, leuprorelin) + Add-back HRT:</strong>
            <ul>
              <li>Induce temporary medical menopause (suppress ovulation completely)</li>
              <li>Very effective (70-80% improvement)</li>
              <li>Requires add-back HRT (low-dose oestrogen + progestogen) to prevent menopausal symptoms and bone loss</li>
              <li>Trial for 6 months - if effective, consider definitive treatment</li>
            </ul>
          </li>
          <li><strong>Bilateral oophorectomy + HRT:</strong>
            <ul>
              <li>Definitive treatment - surgical menopause</li>
              <li>Reserved for severe, refractory PMDD unresponsive to all other treatments</li>
              <li>Requires lifelong HRT (until natural menopause age)</li>
              <li>Only if GnRH analogue trial successful (confirms symptoms ovarian-hormone dependent)</li>
            </ul>
          </li>
        </ul>

        <p><strong>4. Psychological Therapy:</strong></p>
        <ul>
          <li><strong>Cognitive Behavioural Therapy (CBT):</strong> Evidence-based for PMDD - helps manage mood symptoms, coping strategies</li>
          <li>Can be combined with pharmacological treatment</li>
        </ul>

        <p><strong>Treatment Algorithm Summary:</strong></p>
        <ol>
          <li><strong>All patients:</strong> Lifestyle (exercise, diet, stress management) + symptom diary</li>
          <li><strong>Mild-moderate PMS:</strong> Lifestyle + supplements (B6, calcium) ± continuous COCP (Yasmin)</li>
          <li><strong>Severe PMS/PMDD:</strong> Lifestyle + <strong>SSRI (luteal or continuous)</strong> ± CBT</li>
          <li><strong>COCP + SSRI combination:</strong> If either alone insufficient</li>
          <li><strong>Refractory PMDD:</strong> GnRH analogues + HRT → If successful, consider oophorectomy (last resort)</li>
        </ol>

        <p><strong>This patient's management plan (PMDD):</strong></p>
        <ol>
          <li><strong>Education and reassurance:</strong>
            <ul>
              <li>Explain PMDD is a real, treatable condition</li>
              <li>Cyclical hormonal sensitivity (not "just in your head")</li>
              <li>Excellent response to treatment expected</li>
            </ul>
          </li>
          <li><strong>Lifestyle modifications:</strong>
            <ul>
              <li>Regular exercise (30 mins, 5x/week)</li>
              <li>Dietary changes (complex carbs, reduce caffeine/alcohol)</li>
              <li>Stress management techniques</li>
            </ul>
          </li>
          <li><strong>First-line pharmacological: SSRI</strong>
            <ul>
              <li><strong>Sertraline 50mg (luteal phase days 14-28)</strong> OR continuous daily</li>
              <li>Start low, increase to 100-150mg if needed</li>
              <li>Review in 3 months - expect 60-70% improvement</li>
            </ul>
          </li>
          <li><strong>Consider COCP (Yasmin) continuous:</strong>
            <ul>
              <li>Can add to SSRI if partial response</li>
              <li>Suppresses ovulation, eliminates luteal phase</li>
              <li>Provides contraception (family complete)</li>
            </ul>
          </li>
          <li><strong>CBT referral:</strong> Complement pharmacological treatment, coping strategies</li>
          <li><strong>Follow-up:</strong> Continue symptom diary, review in 3 months, adjust treatment as needed</li>
          <li><strong>Prognosis:</strong> Excellent - combination of SSRI + lifestyle ± COCP should provide significant relief</li>
        </ol>
      </div>
    </div>

    <h2>Key Learning Points</h2>
    <div class="key-points">
      <ul>
        <li><strong>PMS</strong> = cyclical physical/psychological symptoms in luteal phase (days 14-28), resolving with menstruation - affects 20-40% women</li>
        <li><strong>PMDD</strong> = severe PMS with predominant mood symptoms causing significant functional impairment - affects 3-8% women</li>
        <li><strong>KEY DIAGNOSTIC FEATURE:</strong> Symptom-free interval in follicular phase (days 1-14) - differentiates from depression/anxiety</li>
        <li><strong>Diagnosis REQUIRES prospective symptom diary</strong> for ≥2 cycles showing luteal phase symptoms + follicular symptom-free interval</li>
        <li><strong>PMDD DSM-5 criteria:</strong> ≥5 symptoms (≥1 core mood symptom: mood swings, irritability, depression, anxiety) + functional impairment</li>
        <li><strong>Lifestyle first-line for ALL:</strong> Exercise (30 mins, 5x/week), diet (complex carbs), stress management, supplements (B6, calcium, magnesium)</li>
        <li><strong>Mild-moderate PMS:</strong> Continuous COCP (Yasmin - drospirenone) suppresses ovulation, eliminates luteal phase</li>
        <li><strong>PMDD first-line pharmacological: SSRIs</strong> (sertraline, fluoxetine) - luteal phase or continuous dosing, 60-70% improvement</li>
        <li><strong>SSRIs work rapidly in PMDD</strong> (within 1-2 days vs 2-4 weeks for depression) - supports serotonin dysregulation theory</li>
        <li><strong>Refractory PMDD:</strong> GnRH analogues + HRT (trial) → oophorectomy (definitive, last resort)</li>
        <li><strong>CBT</strong> effective adjunct for mood symptoms and coping strategies</li>
      </ul>
    </div>

  </div>

  <!-- JavaScript -->  <script src="../js/firebase-config.js"></script>
  <script src="../js/dark-mode.js"></script>
  <script src="../js/auth.js"></script>
  <script src="../js/user-analytics.js"></script>
  <script src="../js/analytics-integration.js"></script>
  <script src="../js/completion-tracker.js"></script>
  <script src="../js/flag-tracker.js"></script>
  <script src="../js/case-interactions.js"></script>

  <script>
    // Toggle case completion
    function toggleCaseCompletion() {
      if (window.completionTracker) {
        const caseId = window.completionTracker.getCurrentCaseId();
        if (caseId) {
          window.completionTracker.toggleCompletion(caseId);
        
    }
      
    }
    
    }
// Toggle case flag
    function toggleCaseFlag() {
      console.log('toggleCaseFlag() function called');
      console.log('window.flagTracker exists:', !!window.flagTracker);

      if (!window.flagTracker) {
        console.error('window.flagTracker is not defined!');
        alert('Flag tracker not initialized. Please refresh the page.');
        return;
      
    }

      const caseId = window.flagTracker.getCurrentCaseId();
      console.log('Current case ID:', caseId);

      if (!caseId) {
        console.error('Could not get case ID');
        alert('Could not determine case ID');
        return;
      
    }

      console.log('Calling window.flagTracker.toggleCaseFlag with caseId:', caseId);
      window.flagTracker.toggleCaseFlag(caseId);
    
    }

    // Update case flag button state on page load
    document.addEventListener('DOMContentLoaded', () => {
      if (window.flagTracker) {
        setTimeout(() => {
          const caseId = window.flagTracker.getCurrentCaseId();
          if (caseId) {
            window.flagTracker.updateCaseFlagButton(caseId);
          
    }
        }, 100);
      
    }
    });
    
    }
  </script>

</body>
</html>
